| Ytd | -10.00% | |
| 1y | 91.49% |
| Open | 81.00 | Prev Close | 81.50 | Low | 81.00 | High | 81.00 | Mkt Cap | 6.83B |
| Vol | 0.00 | Avg Vol | 1.72M | EPS | -5.28 | P/E | -17.05 | Forward P/E | -17.65 |
| Beta | 1.06 | Short Ratio | 0.59 | Inst. Own | 92.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 95.61 | 200-d Avg | 68.01 | 1yr Est | 97.00 |
MRUS News
Advancing Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator, a
YLÖJÄRVI, Finland--(BUSINESS WIRE)--Merus Power Oyj has signed a battery energy storage deal worth a
Federated Hermes Inc. lessened its position in Merus N.V. (NASDAQ: MRUS) by 18.3% during the undefin
Merus N.V. (NASDAQ: MRUS - Get Free Report) has earned an average recommendation of "Hold" from the
Stock News BYD overtakes Tesla in EV sales: Tesla (TSLA) delivered 1.64M vehicles in 2025, ceding th
Stock News U.S. futures rise on first trading day: Tech leaders Nvidia (NVDA), Palantir (PLTR), Appl
Stock News Street sets 2026 expectations: Wall Street sees the S&P 500 posting modest-to-mid-teens g
Merus N.V. (NASDAQ: MRUS - Get Free Report) major shareholder A/S Genmab bought 2,978 shares of Meru
Stock News Buffett hands CEO role to Abel: Berkshire Hathaway (BRK.B) founder Warren Buffett (Trades
Merus N.V. (NASDAQ: MRUS - Get Free Report) major shareholder A/S Genmab acquired 15,710 shares of t
Merus N.V. (NASDAQ: MRUS - Get Free Report) saw some unusual options trading on Friday. Traders acqu
Guru Stock PicksThird Avenue Value Fund has made the following transactions:Reduce in XTER: BMW by 5
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that the
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy
Ensign Peak Advisors Inc increased its stake in Merus N.V. (NASDAQ: MRUS) by 72.4% during the undefi
Bicara Therapeutics (BCAX) is initiated with a Buy rating, driven by promising data for its HNSCC ca
SAN DIEGO and UTRECHT, The Netherlands and CAMBRIDGE, Mass. , Nov. 17, 2025 /PRNewswire/ -- Merus N.
/PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Clas
The market continues to trade deeper in overbought territory based on most traditional valuation met
– 100% response rate in 1L left-sided mCRC (n=8, confirmed and unconfirmed) – 62% response rate in 2
Stocks That Hit 52-Week Lows On Thursday